Clarithromycin Tablet, Film Coated, Extended Release
Product Images NDC 43063-942

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clarithromycin (NDC 43063-942). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063942 Label (43063942)

43063942 Label (43063942)
This is a drug container information with dosage, storage and usage instructions for Clarithromycin ER tablets. The container is light and tight-resistant and is intended to store 14 tablets of 500mg each. It is suggested not to use the drug during pregnancy and to take it with food. The manufacturer is PD-RX Pharmaceuticals, Inc located in Oklahoma City, OK, USA. If side effects persist contact a doctor immediately, and it is recommended to store the tablets at controlled room temperature of 20-25 C.*
FDA Label Image

Chemical Structure For Clarithromycin (Clarithromycin Tab Stucture)

FDA Label Image

Steady State Graph (Clarithromycin Tabs Steady Graph)

Steady State Graph (Clarithromycin Tabs Steady Graph)
This is a chart that compares the mean plasma concentration in patients taking Clarithromycin extended-release (2 x 500mg q24h) versus those taking Clarithromycin (500mg q12h). The chart shows the time after dosing in hours on the bottom and the mean plasma concentration measured in mcg/mL on the side.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.